Acetylcholinesterase Activity Measurement and Clinical Features of Delirium

Thomas A Jackson, Hannah C Moorey, Bart Sheehan, Alasdair M J Maclullich, John R Gladman, Janet M Lord

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)
313 Downloads (Pure)


AIMS: Cholinergic deficiency is commonly implicated in the pathophysiology of delirium. We aimed to investigate the relationship between directly measured serum acetylcholinesterase (AChE) activity and (1) clinical features of delirium and (2) outcomes among older hospital patients with delirium.

METHODS: Hospitalised patients with delirium were recruited, and delirium motor subtype, severity and duration of delirium were measured. Serum AChE activity was measured using a colorimetric assay.

RESULTS: The mean AChE activity for the whole sample was 2.46 μmol/μL/min (standard deviation 1.75). Higher AChE activity was associated with increased likelihood of hypoactive delirium rather than the hyperactive or mixed subtype (odds ratio 1.98, 95% confidence interval 1.10-3.59).

CONCLUSION: Higher AChE activity was associated with hypoactive delirium but did not predict outcomes. Simple enhancement of cholinergic neurotransmission may not be sufficient to treat delirium.

Original languageEnglish
Pages (from-to)29-37
Number of pages9
JournalDementia and Geriatric Cognitive Disorders
Issue number1-2
Early online date15 Dec 2016
Publication statusPublished - 2017


Dive into the research topics of 'Acetylcholinesterase Activity Measurement and Clinical Features of Delirium'. Together they form a unique fingerprint.

Cite this